Phase 1 Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been formally diagnosed with schizophrenia, confirmed through a psychiatric assessment using recognised diagnostic tools and guidelines.
- People whose schizophrenia symptoms are rated as moderate or below on two standard measurement scales, at both an initial screening appointment and a baseline appointment before the trial begins.
- People whose body weight falls within a moderate range relative to their height (a body mass index between 18 and 40).
- People who are willing and able, in the view of the trial doctor, to stop taking all antipsychotic medications before the trial begins and to follow all trial requirements throughout.
Who may not be able to join:
- People who have been newly diagnosed with schizophrenia or are experiencing their first treated episode of the condition.
- People who have been diagnosed with another mental health condition — such as major depression or bipolar disorder — within the past 12 months.
- People who have had an alcohol or drug use disorder within the past 12 months, or who have another significant health condition that could affect their safety or the reliability of the trial results.
- People who are considered to be at risk of suicidal behaviour.
- People who are currently pregnant or breastfeeding.
- Additional criteria set by the trial may also apply (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bristol-Myers Squibb, Bristol-Myers Squibb
Phone: 855-907-3286
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants with adverse events (AEs); Number of participants with adverse events of special interest (AESIs); Number of participants with serious adverse events (SAEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.